Screener
Mirum Pharmaceuticals, Inc. MIRM Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Accrued sales deductions and other | $62,501 | $51,375 |
| Accrued compensation and related benefits | 28,389 | 47,276 |
| Accrued clinical trials | 22,872 | 13,959 |
| Accrued professional service fees | 21,886 | 17,292 |
| Accrued contract manufacturing and non-clinical costs | 17,670 | 8,721 |
| Accrued royalties payable | 16,204 | 16,208 |
| Operating lease liabilities, current | 2,405 | 2,139 |
| Accrued loss on firm purchase commitments | 2,107 | 2,107 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s accrued expenses?
- Mirum Pharmaceuticals, Inc. (MIRM) reported accrued expenses of $28.39M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s accrued expenses changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s accrued expenses increased by 5.8% year-over-year, from $26.84M to $28.39M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s accrued expenses has grown at a 28.7% compound annual growth rate (CAGR), from $13.41M to $47.28M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Mirum Pharmaceuticals, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude